These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3072825)

  • 1. Characterization of multiply resistant Proteus mirabilis isolates in Hungary.
    Konkoly Thege M; Nikolnikov S
    Acta Microbiol Hung; 1988; 35(4):423-8. PubMed ID: 3072825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current state and tendencies of antibiotic resistance in Hungary.
    Thege MK; Bán E
    Acta Microbiol Hung; 1986; 33(2):157-70. PubMed ID: 3811828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY; Ng SY; Teo L; Koh Y; Teok CH
    J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of Proteus resistance to chloramphenicol].
    Shvidenko IG
    Antibiotiki; 1979 May; 24(5):345-8. PubMed ID: 375826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's transl)].
    Schröter G; Loch R
    Zentralbl Bakteriol Orig A; 1979; 245(3):317-23. PubMed ID: 44786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
    Schröter G; Schrettenbrunner A; Strenzel I
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological analysis of Salmonella typhi-murium infections on the basis of laboratory methods. II. Resistance to antibiotics and R-plasmid carrier state in Salmonella typhi-murium isolated in Hungary in the period 1974 to 1981.
    Milch H; László VG; Nikolnikov S
    Acta Microbiol Hung; 1985; 32(1):87-98. PubMed ID: 3898705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-mediated, inducible AmpC beta-lactamase (DHA-1)-producing Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis.
    Yong D; Lim Y; Song W; Choi YS; Park DY; Lee H; Yum JH; Lee K; Kim JM; Chong Y
    Diagn Microbiol Infect Dis; 2005 Sep; 53(1):65-70. PubMed ID: 15936167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-spectrum beta-lactamase in Proteus mirabilis.
    Mariotte S; Nordmann P; Nicolas MH
    J Antimicrob Chemother; 1994 May; 33(5):925-35. PubMed ID: 8089066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.
    D'Andrea MM; Nucleo E; Luzzaro F; Giani T; Migliavacca R; Vailati F; Kroumova V; Pagani L; Rossolini GM
    Antimicrob Agents Chemother; 2006 Feb; 50(2):618-24. PubMed ID: 16436718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
    Szymaniak L; Aleksandrowicz I; Giedrys-Kalemba S
    Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of plasmid-encoded extended spectrum beta-lactamases produced by a clinical strain of Proteus mirabilis.
    Mahrouki S; Ben-Achour N; Chouchani C; Ben-Moussa M; Belhadj O
    Pathol Biol (Paris); 2009 May; 57(3):e55-9. PubMed ID: 18456422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase.
    Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Pournaras S; Markou F
    J Antimicrob Chemother; 2007 Jul; 60(1):136-9. PubMed ID: 17491004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and molecular analysis of extended-spectrum {beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002.
    Ho PL; Ho AY; Chow KH; Wong RC; Duan RS; Ho WL; Mak GC; Tsang KW; Yam WC; Yuen KY
    J Antimicrob Chemother; 2005 Jun; 55(6):840-5. PubMed ID: 15857942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
    Khan AU; Musharraf A
    Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-beta-lactamase VIM-1 in Greece.
    Galani I; Souli M; Koratzanis E; Koratzanis G; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 2007 Mar; 59(3):578-9. PubMed ID: 17255145
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistance to antibiotics of Proteus strains from various sources].
    Korneva EP; Baĭramova AS; Iakh'eva SA; Slutskiĭ VI; Danevich MV
    Antibiotiki; 1984 Apr; 29(4):263-71. PubMed ID: 6378079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid profile analysis and antibiotic resistance of Salmonella strains from clinical isolates in Cluj-Napoca.
    Făgărăşan S; Borza T; Saşcă CI; Rădulescu A; Ionescu M; David E
    Roum Arch Microbiol Immunol; 1997; 56(3-4):127-38. PubMed ID: 9745325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
    Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.